当前位置: 首页 > 期刊 > 《中国当代医药》 > 2018年第16期
编号:13297910
替诺福韦酯肾损害的研究进展(4)
http://www.100md.com 2018年6月5日 《中国当代医药》 2018年第16期
     [17]Rodriguez-Novoa S,Labarga P,Barreiro P,et al.Impair-ment in kidney tubular function in patients receiv-ing tenofovir is associated with higher tenofovirplasma concentration[J].AIDS,2010,24(7):1064-1066.

    [18]Rodriguez-Nóvoa S,Alvarez E,Labarga P,et al.Renal toxicity associated with tenofovir use[J].Expert Opin Drug Saf.2010,9(4):545-559.

    [19]Herlitz LC,Mohan S,Stokes MB,et al.Tenofovir nephrotoxicity:Acute tubular necrosis with distinctive clinical,pathological,and mitochondrial abnormalities[J].Kidney Int.2010, 78(11):1171-7.

    [20]Duarte-Rojo A,Heathcote EJ.Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B[J].Therap Adv Gastroenterol,2010,3(2):107-119.

    [21]顾欣.替诺福韦与非甾体抗炎药联用可能引起急性肾功能衰竭[J].中国处方药,2006(5):69-69.

    [22]李虹,李超锋,刘春礼,等.替诺福韦对肾脏功能的影响[J].临床医学,2013,33(8):57-58.

    [23]陈勇华,曹群奋,洪琼怿.替诺福韦酯治疗对慢性乙型肝炎患者血清FGF-23、β2-MG、Cys-C 及 RBP 水平的影响[J].中国临床药理学与治疗学.2017,22(7):799-804.

    [24]Petersen J,Buti M.Considerations for the long-term treatment of chronic hepatitis B with nucleos(t) ide analogs[J].Expert Rev Gastroenterol Hepatol,2012,6(6):683-693.

    [25]王文茜,潘国洪,伍三兰.替诺福韦致范可尼综合征文献病例分析[J].藥物不良反应杂志,2017,19(4):267-271.

    (收稿日期:2018-01-02 本文编辑:闫 佩), http://www.100md.com(卢美玲 杨晴)
上一页1 2 3 4